Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of ...
Nektar Therapeutics (Nasdaq: NKTR) today announced its financial results for the third quarter ended September 30, 2026, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results